R Squared’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RXRX
AIM
MCMU
R Squared's RXRX Position: Q2 2026 in Review
R Squared reduced its Recursion Pharmaceuticals (RXRX) stake by 36% in Q2 2026, selling an estimated $39.3K and leaving 20,556 shares worth $75.4K. The position accounts for 0.04% of the portfolio, ranked #424.
R Squared first reported a position in RXRX in Q1 2025 and has held it in 6 quarters since. The position peaked at $310K in Q2 2025. 343 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.
- R Squared held 20,556 shares of Recursion Pharmaceuticals worth $75.4K as of Q2 2026.
- R Squared sold 11,807 Recursion Pharmaceuticals shares in Q2 2026, an estimated $39.3K.
- Recursion Pharmaceuticals made up 0.04% of R Squared's portfolio in Q2 2026, its #424 holding.
- R Squared first reported a position in Recursion Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
- R Squared's Recursion Pharmaceuticals position peaked at $310K in Q2 2025.
- 343 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.
Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.